Indivior obtains court order to block generic Suboxone
18-06-2018
Indivior pledges to appeal generic Suboxone decision
26-03-2018
Indivior to appeal court verdict over Suboxone Film patents
04-09-2017
roschetzky / iStockphoto
Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Suboxone, ANDA, Indivior, Par, Endo International, settlement, patent infringement, generics manufacturer
